No matter who’s in office, how long COVID-19 continues, or how the market reacts… one little-known American biotech firm could STILL soar 565% in the next 6 months. Our friends at Stansberry Research break the story below…
The trade picks Dave Lashmet makes in his high-end biotech venture capital service have produced gains as high as 1,139% for his readers.
But a massive gain like that almost always takes some time to play out.
We’re talking years… not months.
That’s why the small American biotech firm Dave Lashmet is currently recommending might be THE most time-sensitive opportunity he has ever recommended.
This stock looks like it’s election-proof, pandemic-proof, AND crash-proof.
Why?
Because the tech they’ve quietly developed could slow down the global pandemic.
This tech has NOTHING to do with masks, cleaning products, or vaccines… which is why this company is practically invisible to investors.
Dave Lashmet now believes that this could be the single most profitable stock of 2020 and 2021…
And an upcoming announcement from the company could trigger a potential 565% profit for investors within just 6 months.
But every second counts for your chance to maximize gains…
See Dave Lashmet’s evidence for yourself and get the critical details right here.
